Hikal informs about quarterly statement on investor complaints

19 Oct 2016 Evaluate

Hikal has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

433.05 18.65 (4.50%)
16-Apr-2025 15:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1692.65
Dr. Reddys Lab 1159.50
Cipla 1499.40
Lupin 1935.80
Zydus Lifesciences 822.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...